Mitochondria, which are the powerhouses of eukaryotic cells, are derived from a bacterial ancestor. Although more than 99% of the original genetic information from this ancestor was transferred to the nuclear genome, mitochondria maintained their own genome (composed of mitochondrial DNA (mtDNA)), which in humans encodes 2 rRNAs, 22 tRNAs and 13 structural subunits of the oxidative phosphorylation (OXPHOS) system. Mitochondria also maintained their own machineries for DNA replication, transcription and translation, all of which consist solely of nuclear-encoded factors that are imported into mitochondria from the cytoplasm. Approximately 25% of mitochondrial proteins are dedicated to these tasks.
It is becoming apparent that mtDNA replication and transcription, RNA modification and also initiation of ribosome assembly are spatially organized in mitochondria. Whereas replication and transcription are linked to mitochondrial nucleoids (which are DNA-protein assemblies), RNA modifications have been associated with mitochondrial RNA (mtRNA) granules [1] [2] [3] . However, these processes are probably not restricted to these foci, as suggested by the spatial assembly of MIOREX (mitochondrial organization of gene expression), which is a large ribonucleoprotein complex in yeast. MIOREX seems to organize mtRNA maturation and decay in association with the mitochondrial ribosome and to some extent with mitochondrial nucleoids 4 . Super-resolution microscopic analyses showed that nucleoids have an average size of ~100 nm and frequently contain a single copy of mtDNA 5 . Moreover, the nucleoids are positioned in close proximity to endoplasmic reticulum (ER)-mitochondria contact sites (for a review, see REF. 6 ) and colocalize with the ER-mitochondria encounter structure (ERMES), which is a protein complex that links the outer mitochondrial membrane to the ER membrane. ERMES has been implicated in lipid exchange and supports the distribution of mitochondria within the cell. Given the spatial link between nucleoids and ERMES, it is likely that ER-mitochondri a contact sites are important for the distribution of mtDNA upon divisio n of mitochondria 7 . The human double-stranded mtDNA is transcribed into two polycistronic transcripts, which are cleaved into individual RNA molecules, including nine monocistronic and two bicistronic mRNAs, rRNAs and tRNAs, before translation of the mRNAs. It is apparent that defects in mitochondrial RNA processing and maturation affect mitochondrial RNA stability and protein expression 3, [8] [9] [10] . In contrast to yeast, mammalian mitochondrial transcripts lack a significant 5ʹ untranslated region (UTR). Whereas in yeast, mitochondrial trans lational regu lation is tightly linked to mRNA-specific translational activators, which bind to cognate mRNAs to stimulate their trans lation
, mammalian mitochondrial ribosomes are challenged with the task of recognizing transcripts in the absence of mRNA-bindin g translational activators.
Recent studies provided initial insights into the regulation of translation in human mitochondria. For example, the trans lation of COX1, the mitochondrial-encoded core subunit of the OXPHOS complex cytochrome c oxidase (COX; also known as complex IV), is regulated by a translational feedback loop involving subunits of an early assembly intermediate termed MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase). In addition, the findings that microRNAs (miRNAs) have a translational regulatory capacity within mitochondria, and that mitochondrial translation can modulate cell proliferation, shed light on the cellular context of the regulation of mitochondrial gene expression. Excellent reviews address the basic mechanisms of mammalian mitochondrial gene expression 11 . However, recent findings suggest that the mitochondrial protein synthesis system might be influenced or controlled by unexpected means, which may help to match mitochondrial gene expression with cellular demands. In this Progress article, we attempt to highlight some of the emerging ideas on the regulation of mitochondrial translation and discuss suggested concepts on links between translation and mtRNA modification, ribosome assembly and respiratory chain assembly processes. We discuss developing views on how mitochondrial translation is integrated into the cellular context through miRNA-mediated regulation of mitochondrial translation, and a potential role for a mitochondrial ribosomal protein (MRP) in the cytosolic stress response.
Mitochondrial interconnections
The synthesis and subsequent assembly of mtDNA-encoded proteins into inner membrane complexes are not isolated processes. In fact, tight links exist between the processing and maturation of mitochondrial transcripts, a dedicated mitochondrial translation machinery and assembly factors of the respiratory chain, in order to avoid accumulation of non-assembled proteins in the inner membrane.
RNA processing, maturation and stability. Mammalian mitochondrial mRNAs originate from two polycistronic transcripts, one from each mtDNA strand. Therefore, similar stabilities and steady state levels would be expected for the individual mtRNAs. However, after RNA processing, which is mediated by RNase P at the 5ʹ end and by zinc phosphodiesterase ELAC protein 2 (ELAC2) at the 3ʹ end 12, 13 (FIG. 1a) , the half-lives of the mitochondrial transcripts Abstract | Mitochondrial-encoded subunits of the oxidative phosphorylation system assemble with nuclear-encoded subunits into enzymatic complexes. Recent findings showed that mitochondrial translation is linked to other mitochondrial functions, as well as to cellular processes. The supply of mitochondrial-encoded proteins is coordinated by the coupling of mitochondrial protein synthesis with assembly of respiratory chain complexes. MicroRNAs imported from the cytoplasm into mitochondria were, surprisingly, found to act as regulators of mitochondrial translation. In turn, translation in mitochondria controls cellular proliferation, and mitochondrial ribosomal subunits contribute to the cytoplasmic stress response. Thus, translation in mitochondria is apparently integrated into cellular processes.
differ significantly, with mitochondrial mRNAs being classified as either short-lived or long-lived transcripts 14 . Interestingly, the steady state levels and half-lives of mitochondrial mRNAs seem to correlate with the overall quantity of the corresponding OXPHOS complexes 8 . This raises the question of how the stability of individual mRNAs is regulated in mitochondria before the translation process. The current view is that mitochondrial mRNA-specific factors associate with their cognate mRNA to protect it from degradation by the mitochondrial degradosome, which is a complex comprising polynucleotide phosphorylase (PNPase; also known as PNPT1) and the ATP-dependent RNA helicase Suppressor of Var1 3-like protein 1 (SUPV3L1) 15 . Several factors that are crucial for mitochondrial mRNA stability have been identified in mammals: Leu-rich PPR motif-containing protein (LRPPRC), which forms a complex with SRA stem-loop-interacting RNAbinding protein (SLIRP), stabilizes most mitochondrial mRNAs 16 by stimulating the mitochondrial poly(A) RNA polymerase and thus polyadenylation 17 . Consistent with this, a study that investigated the effect of a loss of potential mtRNA-binding proteins on mitochondrial transcripts confirmed that mitochondrial mRNA stability is affected by LRPPRC 8 . Interestingly, the loss of the LRPPRC-SLIRP complex primarily affected the abundance of heavy-strand precursor transcripts. Moreover, these studies identified FAST kinase domain-containing protein 4 (FASTKD4; also known as TBRG4) as a mtRNA-associated protein that specifically stabilizes mitochondrial mRNAs encoding COX1, COX2, COX3, ATP synthase subunit a (ATP6), ATP synthase protein 8 (ATP8), cytochrome b (CYTB; also known as mtCYB) and NADH dehydrogenase subunit 3 (ND3). In a complementary manner, a related protein, FAS-activated Ser/Thr kinase (FASTK), stabilizes and regulates the biogenesis of the ND6-encoding transcript by binding to multiple sites of ND6 mRNA 18 . The factors that are required for p rocessing and stability of mtRNAs include G-rich sequence factor 1 (GRSF1) 2, 3 . GRSF1 interacts specifically with RNase P and was suggested to be involved in early RNA processing events 3 . According to this suggestion, loss of GRSF1 results in decreased levels of several mature mitochondrial mRNAs and mitochondrial rRNAs, accompanied by an accumulation of their precursors owing to impaired cleavage. As a consequence, translation of mtDNAencoded proteins is significantly decreased when GRSF1 function is lacking 2, 3 . Thus, proper processing of mitochondrial precursor transcripts is mandatory for their subsequen t translation.
The first steps of mtRNA processin g occur in defined foci, called mtRNA granules, which contain GRSF1, RNase P, probable ATP-dependent RNA helicase DDX28, putative ATP-dependent RNA helicase DHX30, FASTKD2, FASTKD5, FASTK and nascent mtRNA [1] [2] [3] 9, 10, 18 . This spatial organization of RNA maturation seems to be crucial for mitochondrial gene expression. Similarly, tight spatial organization of mtDNA with gene expression factor s within mitochondrial nucleoids has been found to be required for replication and transcription, and RNA-processing enzymes were shown to be enriched near nucleoids 1 . As a set of MRPs were found to be associated with nucleoids and mtRNA granules in mammalian mitochondria, it has been suggested that the initial steps of RNA processing and mitochondrial ribosome assembly are spatially coordinated at nucleoids and at mtRNA granules, indicating that there is tight coupling between transcription, RNA maturatio n and translation events 1, 9, 10 (FIG. 1a) .
A closer look at the mitochondrial ribosome. Mitochondrial ribosomes are dedicated to the translation of mitochondrial mRNAs that encode membrane proteins. Consistent with this function, mitochondrial ribosomes are mainly localized to the inner mitochondrial membrane, where insertion of membrane proteins occurs co-translationally. Cryo-electron tomography analyses of yeast mitochondrial ribosomes showed that most Nature Reviews | Molecular Cell Biology
Box 1 | Translational activators in yeast regulate mRNA-specific translation
Yeast mitochondrial transcripts differ from their human counterparts in having long 5ʹ and 3ʹ untranslated regions (UTRs). Translational activators bind to the 5ʹ UTRs in a mRNA-specific manner to facilitate initiation of translation. Each transcript possesses at least one particular translational activator. The mitochondrial-encoded ribosomal subunit Var1 requires the activator synthesis of Var1 (Sov1), whereas five activators have been described for the translation of the complex III component cytochrome b, namely cytochrome b synthesis 1 (Cbs1), Cbs2, cytochrome b mRNA-processing 1 (Cbp1), Cbp3 and Cbp6. The subunits of complex IV require the translational activators petite colonies 309 (Pet309) and mitochondrial splicing suppressor 51 (Mss51) for cytochrome c oxidase 1 (COX1), Pet111 for COX2, and Pet54, Pet122 and Pet494 for COX3. Translational activators for complex V are ATPase synthase 22 (Atp22) for ATP6 and ATP8, and ATPase expression 1 (Aep1) and Aep2 for ATP9 (REF. 55 ). Interestingly, regulatory feedback mechanisms, which involve translational activators, have been described to coordinate the synthesis and the subsequent assembly of mitochondrial DNA (mtDNA)-encoded subunits into their assigned complexes. This is exemplified by the dual role of Mss51, which interacts with the COX1 mRNA as a translational activator, and with the Cox1 protein in early assembly intermediates of complex IV as an assembly factor (see the figure) . Recruitment of Mss51 into Cox1-containing assembly intermediates leads to inactivation of Mss51, by an undefined mechanism, and concomitantly reduces translation of the COX1 mRNA. This mechanism allows mitochondria to adapt the supply of Cox1 to the velocity of cytochrome c oxidase assembly, preventing accumulation of potentially harmful non-assembled subunits [56] [57] [58] [59] . Recently Mss51 was shown to be a haem b-containing protein. The haem association regulates the activation of COX1 mRNA translation by Mss51 by an unknown mechanism. This finding suggests that translational regulation is tightly linked to haem metabolism, either by sensing oxygen levels through the haem b moiety (O 2 is required for haem biosynthesis) or by haem availability for Cox1 biogenesis 60 . Likewise, translation of cytochrome b has recently been shown to be tightly controlled by incorporation of haem b into assembly intermediates 61 . By contrast, mammalian mitochondrial transcripts lack significant 5ʹ UTRs and, in most cases, 3ʹ UTRs. Hence, it is not surprising that most of the yeast translational activators do not have human orthologues or that different mechanisms have evolved to regulate translation in human mitochondria. Coa, cytochrome c oxidase assembly; IMM, inner mitochondrial membrane; IMS, intermembrane space; Oxa1, cytochrome oxidase activity 1; Shy1, SURF1 homologue of yeast.
ribosomes are bound to the membrane as polyribosomes 19 . Their membrane association is mediated by inner membrane mitoribosome receptor Mba1 (MRPL45 in mammals), which is a ribosome-associated protein that binds to the ribosomal large subunit (mtLSU) close to the exit tunnel. In addition to Mba1, yeast mitochondrial ribosomes possess a second physical connection to the inner mitochondrial membrane. Interestingly, this second membrane tether is formed by an extension of the mitochondrial rRNA, 96-ES1 (REF. 19 ).
Despite the fact that mitochondrial ribosomes are derived from bacterial ancestors, the available structural analyses show that substantial differences exist between the two 20 . Here, we discuss selected structural aspects of the mammalian mitochondrial ribosome. Unlike bacterial ribosomes, the mammalian mitochondrial ribosome is composed of a 28S small subunit (mtSSU) and a 39S mtLSU, forming a 55S particle with a molecular weight of 2.7 MDa, which differs considerably from the bacterial ribosome (2.3 MDa). The 28S mtSSU contains 30 MRPs (termed MRPSs) and the mtDNAencoded 12S rRNA. The 39S mtLSU contains 50 MRPs (MRPLs) and the 16S rRNA. The mitochondrial rRNAs are significantly shorter than their bacterial counterparts, whereas the protein content of the mammalian mitochondrial ribosome has increased substantially. This is explained by the fact that some mammalian MRPSs, which are homologous to bacterial subunits, acquired amino-and carboxy-termina l extensions and that the mitochondrial ribosome has co-opted additional proteins that are not present in the bacterial ribosome. Approximately 50% of mitochondrial ribosomal subunits have no bacterial counterpart, leading to a reversed RNA/protein ratio of 30:70% (compared to 70:30% in the bacterial ribosome). It has been speculated that the gain of protein mass compensates for the loss of mitochondrial rRNA. However, mitochondria-specific ribosomal proteins occupy new positions within the ribosome, and the recruitment of novel MRPs took place early in eukaryote evolution, before mitochondrial rRNAs in metazoa were reduced in length [20] [21] [22] . As many rRNA residues that are required for binding to tRNAs, especially within the E-site of the bacterial ribosome, are missing in the mammalian mitochondrial ribosome, it has been speculated that a comparable E-site is absent 20 . However, recent cryoelectro n microscopy (cryo-EM) analysis of the porcine and human 39S mtLSU demonstrated the presence of a tRNA-occupied , are assembled with imported mitochondrial ribosomal proteins (MRPs) of the 39S mitochondrial large subunit (mtLSU), termed MRPLs, and of the 28S small subunit (mtSSU), termed MRPSs, thus initiating the first steps of ribosome assembly. MRPLs and MRPSs are presented in an unfolded state in the cytosol prior to import and in a processed and matured form within mitochondria (shown as pink circles). b | COX1 synthesis and COX complex assembly. MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase) assembles on newly synthesized COX1, which is inserted into the IMM by mitochondrial inner membrane protein OXA1L. The early form of MITRAC (MITRAC early ) includes cytochrome c oxidase assembly protein C12ORF62 and MITRAC12, which associate with COX1 and stimulate its translation (top). Even though the molecular mechanisms by which C12ORF62 and MITRAC12 affect translation have not been determined, the current view is that regu lation of translation by assembly factors helps to avoid accumulation of non-assembled intermediates. Later during COX complex assembly, additional factors are recruited to MITRAC late , including surfeit locus protein 1 (SURF1), MITRAC15 and COX assembly mitochondrial protein (CMC1) (bottom). Mitochondrial import inner membrane translocase subunit TIM21, which is a transient component of MITRAC, promotes COX assembly by transporting newly imported complex IV subunits, such as COX subunit 4 isoform 1 (COX4I1), from the TIM23 complex to MITRAC. IMS, intermembrane space; OMM, outer mitochondrial membrane; TOM, translocase of the outer membrane. E-site 23, 24 . The structural information that is now available provides an important framework in which regulatory and mechanistic questions, such as the mechanism of translation termination, can be studied. One un expected result of the cryo-EM analyses was the identification of two components of the mtSSU, namely MRPS30 and MRPS18A, as components of the 39S mtLSU. The molecular function of these proteins remains to be defined. Interestingly, MRPS18 exists in three isoforms (MRPS18A, MRPS18B and MRPS18C). MRPS18C occupies the same location within the ribosomal SSU as its bacterial counterpart S18, whereas MRPS18B binds to a different site of the 28S mtSSU, demonstrating that the three isoforms occupy distinct sites within the mammalian mitochondrial ribosome and not a single site as previously assumed 25, 26 . Although structural data on the mitochondrial ribosome are essential for improving our functional understanding of mitochondrial translation, they also have pathological relevance. During the past decade, several human disorders have been found to be caused by mutations in genes encoding MRPs. So far mutations have been identified in genes encoding MRPS7, MRPS16, MRPS22, MRPL3, MRPL12 and MRPL44 (REFS 27-35) (see Supplementary information S1 (figure)). Remarkably, these mutations lead to very distinct clinical phenotypes affecting different tissues. One explanation for this could be that ribosome function is modulated in a cell type-specific manner.
The very recent observation that MRPL18, which is a component of the 39S mtLSU, also has functions in the cytoplasm suggested that MRPs might not be restricted to their task within the mitochondrial ribosome 36 . Under stress conditions, a cytosolic isoform of MRPL18 is generated from an alternative start codon. This cytosolic isoform is incorporated into the cytosolic 80S ribosome, where it is required for expression of heat shock proteins during stress. Surprising findings were also made regarding the identity of mitochondrial rRNAs, solving a long-standing debate in the field about the potential existence of a 5S rRNA within the mammalian mitochondrial ribosome. In contrast to bacterial and cytosolic ribosomes, where three rRNA molecules are required for the assembly of a functional ribosome, the mammalian mitochondrial ribosome is lacking a 5S rRNA; instead, it comprises two rRNA molecules and tRNA Val , which was identified in the 39S mtLSU 23, 24 .
As the gene encoding tRNA
Val is positioned between the 12S rRNA and 16S rRNA genes in the mitochondrial genome (FIG. 1a) , tRNA Val is present in stoichiometric amounts relative to the rRNAs after RNA processing. On the basis of the observed position of tRNA Val , it is tempting to speculate that mutations in tRNA Val might not only lead to defects during translation elongation but also affect the assembly and composition of the human mitochondrial ribosome.
Linking assembly and translation. Whereas in yeast, mitochondria translational activators seem to link assembly of the OXPHOS complexes to the synthesis of mitochondrialencoded proteins
, the lack of 5ʹ UTRs and translational activators in human mitochondria means that alternative strategies are required to regulate translation, in order to adapt the supply of mitochondrialencoded proteins to the influx of imported subunits and to the incorporation of cofactors. The recent identification of proteins that constitute the COX assembly intermediate MITRAC provides insight into how mitochondrial translation is coupled to COX assembly in human cells [37] [38] [39] [40] (FIG. 1b) .
MITRAC assembles on newly synthesized COX1 to accompany the initial steps of COX assembly. The complex contains several assembly factors, including surfeit locus protein 1 (SURF1), C12ORF62 (also known as COX14), COX assembly mitochondrial protein 1 (CMC1), MITRAC12 (also known as COA3) and MITRAC15 (also known as COA1). In addition, MITRAC associates with mitochondrial import inner membrane translocase subunit TIM21, a constituent of the TIM23 complex, which is the translocase of the inner membrane that mediates the import of presequence-containing proteins into the matrix and the inner mitochondrial membrane. TIM21 shuttles such newly imported nuclear-encoded subunits destined for COX from the translocase to MITRAC 39 . These findings showed that the assembly of COX is a highly regulated process that requires coordination between the import of nuclear-encoded proteins and the synthesis of mitochondrial-encoded proteins (FIG. 1b) .
A dysfunction of MITRAC is associated with COX deficiency, which results in severe human mitochondrial disorders, as demonstrated by mutations in SURF1, C12ORF62 and MITRAC12 (REFS 37, (40) (41) (42) . Remarkably, the COX deficiency in patients with mutated C12ORF62 and MITRAC12 is accompanied by a selective reduction in COX1 synthesis (see Supplementary information S1 (figure) ), owing to the loss of function of C12ORF62 or MITRAC12, as ectopic expression of the respective wild-type proteins in a mutant cell line restored the levels of COX1 synthesis 37, 40 . In addition, depletion of C12ORF62 or MITRAC12 could reproduce the phenotype of decreased COX1 translation 37, 39 . Both C12ORF62 and MITRAC12 are components of the MITRAC complex of an early COX assembly state, whereas other components such as SURF1, which is not required for COX1 synthesis, seem to have roles at a later stage in COX assembly 43 (FIG. 1b) .
The above observations showed that in mammalian mitochondria, defective COX assembly results in a negative feedback mechanism, which reduces the synthesis and supply of COX1. However, the molecular details of this process remain to be assessed. A link between translation and assembly has not only been observed for complex IV. Similar regulatory mechanisms have been reported for human complex III 44 . Ubiquinolcytochrome c reductase complex assembly factor 1 (UQCC1) and UQCC2 were suggested to be involved in translation or stability of the mtDNA-encoded complex III subunit CYTB. Individuals with mutations in UQCC2 are characterized by a severe reduction in newly synthesized CYTB. Additionally, the UQCC2 binding partner, UQCC1, was shown to interact with newly synthesized CYTB. Therefore, it is tempting to speculate that regulatory translation-feedback mechanisms also exist for complex III and probably also for complexes I and V, all of which have mitochondrial-encoded subunits. Cellular links to mitochondrial translation As described above, mitochondrial translation is influenced by and subject to various mitochondrial processes. Interestingly, recent studies indicate that mitochondrial translation is strongly influenced by the cellu lar environment. Furthermore, it seems that mitochondrial translation may also affect cellula r processes in a retrograd e manne r (FIG. 2) . miRNAs regulate mitochondrial translation. miRNAs have a crucial role in regulating translation in the cytoplasm through their ability to target Argonaute 2 (AGO2)-containing RNA-induced silencing complexes to mRNAs, thereby mediating inhibition of translation and mRNA decay 45 .
Recently, a regulatory function was reported for AGO2 with a mitochondria-targeted miRNA, miR-1 (REF. 46) (FIG. 2a) . AGO2 was found to be localized in the mitochondrial matrix with miR-1, but its binding partner GW182 (also known as TNRC6A), which is required for gene silencing in the cytosol by recruiting deadenylation and decapping enzymes, was not found in mitochondria. Thus, in mitochondria, miRNAs and AGO2 might have functions other than gene silencing; indeed, miR-1 and AGO2 were found to bind to the mRNA of MTCO1 and MTND1 (complex IV and complex I sub units, respectively) and to enhance rather than repress their translation during muscle differentiation 46 . Accordingly, the levels of AGO2 and miR-1 in the mitochondria are increased in differentiated myotubes compared to myoblasts. In addition, enhanced synthesis of CYTB, COX3 and ATP8 mediated by miR-1, enhanced synthesis of ND4L mediated by miR-499-5p, and enhanced synthesis of ND1 mediated by miR-101 and miR-499-5p were reported 46 . It is tempting to speculate that additional miRNAs are targeted to mitochondria to increase and regulate the level of mitochondrial-encoded proteins under defined physiological conditions. The dual function of miRNAs in the cytosol and in mitochondria demonstrates a tight and unexpected link between mitochondrial gene expression and cellular processes and indicates a central role for mitochondrial translatio n in cellular functions.
Mitochondrial translation controls cell proliferation.
Various studies have hinted at the possibility that mitochondrial translation is able to affect processes outside the mitochondrion. These analyses reported that mitochondrial translational deficiency impairs proliferation of mammalian cells cultured in glucose-containing medium [47] [48] [49] [50] [51] (FIG. 2b) . Considering that cultured cells obtain most of their energy through glycolysis, this proliferation defect cannot be simply explained by defective OXPHOS. What, then, causes the impaired proliferation in mitochondrial translation-deficient cells? Cells treated with the drug actinonin, which inhibits the mitochondrial peptide deformylase and eventually leads to pausing of translation elongation, had a proliferation defect 50 . Interestingly, the addition of chloramphenicol, another inhibitor of mitochondrial translation, which occupies the ribosomal A-site, was found to counteract this effect. This observation is explained by the fact that the stalled ribosomes in actinonin-treated cells activate a 'rescue pathway' , which releases the nascent peptide chain from the tRNA in the P-site through a class I release factor. Current models suggest that this rescue pathway, which allows the rescue of ribosome function, also initiates a retrograde signalling process to the nucleus, which eventually inhibits cell proliferation 52 . As chloramphenicol acts at the ribosomal A-site, the release factor cannot enter the ribosome in the presence of this drug and, consequently, the rescue pathway and its downstream events are blocked. What is the retrograde signal? Actinonin treatment leads to processing of the mitochondrial fusion component optic atrophy protein 1 (OPA1) and thus induces fragmentation of the mitochondrial network 50 . This process is reversed by chloramphenicol treatment.
It remains an open question whether processing of OPA1 and mitochondrial fragmentation are components of the retrograde signalling process or just consequences of mitochondrial stress. However, since processing of OPA1 is initiated by loss of the mitochondrial membrane potential 53, 54 , it is tempting to speculate that this process is caused by ribosomal stalling, which might be associated with the synthesis of aberran t proteins that lead to depolarization of the mitochondrial membrane. At the same time, depolarization affects translocation of nuclear-encoded proteins and eventually causes accumulation of precursors in the cytosol that are subjected to quality-control processes. Accordingly, it is speculated that relocalization of mitochondrial proteins to the cytosol could contribute to signalling processes 52 . Although we still lack insight into the signalling processes and triggering molecules, these observations indicate that mitochondrial translation affects communications between the nucleus, the cytoplasm and mitochondria.
Conclusion and perspectives
It is becoming evident that mitochondrial translation is not an isolated process but is highly coordinated with and influenced by the cellular environment. The efficient assembly of the OXPHOS system from subunits of dual genetic origin (nuclear and mitochondrial) requires coordination between the import of nuclear-encoded subunits and the synthesis of proteins in mitochondria. It is likely that the coordination of these processes occurs in a spatial and temporal manner. An important aspect of the regulation of mitochondrial translation is prevention of the toxic accumulation of nuclear-encoded mitochondrial membrane proteins at the surface of mitochondria, as well as protection of mitochondria from an overabundance of mitochondrial-derived proteins. At the same time, as a consequence of mitochondrial translation stress, retrograde signalling pathways appear to exist and to communicate from mitochondria to other compartments in the cell. It is tempting to speculate that the organization of the mitochondrial network within cells and the distribution of mitochondrial protein functions with regard to contacts between mitochondria and other compartments have important roles in integrating mitochondrial protein synthesis and retrograde signallin g with the cellular environment.
